U.S. Biotech

topic on 1 show · 1 statements across 1 episodes

1 statements about U.S. Biotech, every show

Beam: U.S. Biotech Lagging China Is Regulatory, Not an Innovation Deficit

“The reason why U.S. Biotech is losing to Chinese biotech is not because of an innovation problem. There's a regulatory framework too that has to go to enabling like fast clinical trials.”

Andy Beam Jul 16, 2026 ▶ 54:37 🔬 RL with Verifiable Rewards, but the Verifier is a Lab — Lila Sciences

← every entity, every show

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

U.S. Biotech

1 statements about U.S. Biotech, every show

Turn any episode into a week of clips.